ROSTI, GIANANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 859
EU - Europa 335
AS - Asia 176
AF - Africa 31
OC - Oceania 23
SA - Sud America 14
Totale 1.438
Nazione #
US - Stati Uniti d'America 834
FR - Francia 69
IT - Italia 57
SA - Arabia Saudita 45
GB - Regno Unito 44
IE - Irlanda 40
CN - Cina 38
DE - Germania 34
VN - Vietnam 30
BG - Bulgaria 29
AU - Australia 23
CA - Canada 21
IN - India 15
FI - Finlandia 12
CH - Svizzera 9
ZA - Sudafrica 8
DZ - Algeria 7
ID - Indonesia 7
PL - Polonia 7
NL - Olanda 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
KR - Corea 5
MA - Marocco 5
SG - Singapore 5
BR - Brasile 4
CL - Cile 4
ES - Italia 4
MX - Messico 4
PT - Portogallo 4
UA - Ucraina 4
EC - Ecuador 3
EG - Egitto 3
ET - Etiopia 3
MY - Malesia 3
OM - Oman 3
TR - Turchia 3
TW - Taiwan 3
BE - Belgio 2
CO - Colombia 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
LB - Libano 2
NO - Norvegia 2
PK - Pakistan 2
SI - Slovenia 2
TN - Tunisia 2
AL - Albania 1
AT - Austria 1
DK - Danimarca 1
GH - Ghana 1
IQ - Iraq 1
LK - Sri Lanka 1
NG - Nigeria 1
PY - Paraguay 1
RU - Federazione Russa 1
SD - Sudan 1
SE - Svezia 1
TH - Thailandia 1
YE - Yemen 1
Totale 1.438
Città #
Santa Cruz 78
Ashburn 61
Woodbridge 54
Buffalo 53
Seattle 53
Fairfield 49
Houston 43
Dublin 40
Riyadh 40
Sofia 29
Chicago 22
Boardman 21
Cambridge 21
Bologna 19
Dong Ket 18
Wilmington 17
New York 15
Ann Arbor 13
Mountain View 13
Exeter 11
Las Vegas 11
Helsinki 10
San Diego 10
Bremen 9
Council Bluffs 9
Perth 9
Los Angeles 8
Ottawa 8
Southend 8
Clearwater 7
Warsaw 7
Dallas 6
Muizenberg 6
Cedar Knolls 5
Jakarta 5
Nanjing 5
Paris 5
Casablanca 4
Changsha 4
Phoenix 4
Provo 4
Riva 4
San Francisco 4
Alpharetta 3
Atlanta 3
Brüttisellen 3
Büdelsdorf 3
Cairo 3
Frankfurt Am Main 3
Hamilton 3
Hsinchu County 3
Jacksonville 3
Jena 3
Melbourne 3
Milpitas 3
Quito 3
Shah Alam 3
Toronto 3
Aksum 2
Amsterdam 2
Bhubaneswar 2
Bloomsbury 2
Bogotá 2
Boniswil 2
Cheyenne 2
Chihuahua City 2
Chongqing 2
El Aouinet 2
Forlì 2
Hefei 2
Henderson 2
Imola 2
Karachi 2
Kirkland 2
Lake Forest 2
Lucca 2
Miami 2
Montreal 2
Mumbai 2
Munich 2
Piacenza 2
Porto 2
Pune 2
Přerov 2
Recife 2
Rennes 2
Rochester 2
Rockingham 2
Sacramento 2
San Jose 2
San Lazzaro di Savena 2
Settimo Torinese 2
Sheffield 2
Siena 2
Singapore 2
Trondheim 2
University Park 2
Wuhan 2
Aalst 1
Accra 1
Totale 949
Nome #
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview, file e1dcb337-eb0b-7715-e053-1705fe0a6cc9 374
Consensus conference on the management of tumor lysis syndrome., file e1dcb331-ceac-7715-e053-1705fe0a6cc9 122
Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice, file e1dcb334-9623-7715-e053-1705fe0a6cc9 117
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia, file e1dcb32e-e0e1-7715-e053-1705fe0a6cc9 114
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants, file e1dcb32e-cb30-7715-e053-1705fe0a6cc9 90
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: A position paper, file e1dcb333-f2ff-7715-e053-1705fe0a6cc9 77
Residual peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission, file e1dcb335-2d69-7715-e053-1705fe0a6cc9 69
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment, file e1dcb334-e5ae-7715-e053-1705fe0a6cc9 67
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia, file e1dcb330-4aea-7715-e053-1705fe0a6cc9 63
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors, file e1dcb332-e6a2-7715-e053-1705fe0a6cc9 62
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients., file e1dcb32e-cf5e-7715-e053-1705fe0a6cc9 58
Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia, file e1dcb335-7389-7715-e053-1705fe0a6cc9 51
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia, file e1dcb332-80d5-7715-e053-1705fe0a6cc9 21
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors, file 8c4fbec8-d0ba-46ea-ac30-2cf21af6879a 18
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia, file e1dcb332-80d1-7715-e053-1705fe0a6cc9 17
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia, file e1dcb332-80d3-7715-e053-1705fe0a6cc9 17
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia, file e1dcb332-80d4-7715-e053-1705fe0a6cc9 17
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia, file e1dcb332-80d6-7715-e053-1705fe0a6cc9 16
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia, file e1dcb335-14cf-7715-e053-1705fe0a6cc9 12
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance, file e1dcb32e-de65-7715-e053-1705fe0a6cc9 11
Current treatment approaches in CML., file facd034c-5d4b-4e46-9b04-3fea2a5d765b 11
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs), file e1dcb331-0af5-7715-e053-1705fe0a6cc9 10
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia, file e1dcb336-c3f5-7715-e053-1705fe0a6cc9 8
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia, file 0b6db5c0-d440-485e-9f6b-321718215366 7
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR), file e1dcb330-ea71-7715-e053-1705fe0a6cc9 7
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia, file e1dcb32c-daa1-7715-e053-1705fe0a6cc9 6
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview, file e1dcb337-e3fc-7715-e053-1705fe0a6cc9 6
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview, file e1dcb337-e3fd-7715-e053-1705fe0a6cc9 6
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study, file 90453892-ecd7-4dce-9c53-c671f76120c9 4
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study, file c1380f92-fec3-4a23-ae61-d2ae037435e2 4
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: Molecular cytogenetic characterization and influence on TKIs therapy, file e1dcb330-c14f-7715-e053-1705fe0a6cc9 4
Managing chronic myeloid leukemia for treatment-free remission: A proposal from the GIMEMA CML WP, file e1dcb333-f43f-7715-e053-1705fe0a6cc9 4
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights, file 902efd85-6eb6-494c-b53b-132bf388035b 3
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients, file e1dcb32e-e051-7715-e053-1705fe0a6cc9 3
Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia, file e1dcb330-3cf4-7715-e053-1705fe0a6cc9 3
null, file e1dcb337-ff08-7715-e053-1705fe0a6cc9 2
Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib, file e1dcb32e-d80b-7715-e053-1705fe0a6cc9 1
null, file e1dcb32e-ddc7-7715-e053-1705fe0a6cc9 1
A review and an update of European leukemianet recommendations for the management of chronic myeloid leukemia, file e1dcb330-7faf-7715-e053-1705fe0a6cc9 1
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview, file e1dcb337-eb0e-7715-e053-1705fe0a6cc9 1
Totale 1.485
Categoria #
all - tutte 4.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020142 6 0 0 5 15 14 17 14 18 20 11 22
2020/2021213 11 36 2 14 13 19 19 21 22 6 31 19
2021/2022397 24 16 24 27 31 18 19 28 40 21 107 42
2022/2023405 5 23 91 50 22 21 17 15 81 16 52 12
2023/2024324 13 22 24 40 22 73 70 21 26 13 0 0
Totale 1.485